Anna Berkenblit

Insider Reports History

Entity
Individual
Location
830 Winter Street, Waltham, Massachusetts
Signature
/s/Charles Williams, Attorney-in-Fact for Anna Berkenblit
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Anna Berkenblit:

Stock Role Class Num Shares Value Price $ Report Date Ownership
ImmunoGen, Inc. SVP & CHIEF MEDICAL OFFICER Common Stock 114K $3.38M $29.64 Jun 30, 2023 Direct
ImmunoGen, Inc. SVP & CHIEF MEDICAL OFFICER Restricted Stock Unit 63.4K $1.86M $29.40 Feb 3, 2023 Direct
ImmunoGen, Inc. SVP & CHIEF MEDICAL OFFICER Stock Option (right to buy) 256K $1.33M $5.19 Feb 3, 2023 Direct
Surrozen, Inc./DE Director Option (right to buy) 1.33K Jun 5, 2024 Direct

Insider Reports Filed by Anna Berkenblit

Symbol Company Period Transactions Value $ Form Type Date Filed Role
SRZN Surrozen, Inc./DE Jun 5, 2024 1 $0 4 Jun 6, 2024 Director
IMGN ImmunoGen, Inc. Jun 30, 2023 1 $13.2K 4 Jul 5, 2023 SVP & CHIEF MEDICAL OFFICER
SRZN Surrozen, Inc./DE May 18, 2023 1 $0 4 May 22, 2023 Director
IMGN ImmunoGen, Inc. Feb 3, 2023 3 $0 4 Feb 7, 2023 SVP & CHIEF MEDICAL OFFICER
IMGN ImmunoGen, Inc. Dec 30, 2022 1 $1.71K 4 Jan 3, 2023 SVP & CHIEF MEDICAL OFFICER
IMGN ImmunoGen, Inc. Jun 30, 2022 1 $11.8K 4 Jul 5, 2022 SVP & CHIEF MEDICAL OFFICER
SRZN Surrozen, Inc./DE Jun 7, 2022 1 $0 4 Jun 9, 2022 Director
IMGN ImmunoGen, Inc. May 20, 2022 2 $0 4 Dec 27, 2022 SVP & CHIEF MEDICAL OFFICER
IMGN ImmunoGen, Inc. Feb 4, 2022 1 $1.66M 4 Feb 8, 2022 SVP & Chief Medical Officer
IMGN ImmunoGen, Inc. Dec 31, 2021 1 $9.86K 4 Jan 4, 2022 SVP & Chief Medical Officer
SRZN Surrozen, Inc./DE Aug 11, 2021 0 $0 3 Aug 16, 2021 Director
IMGN ImmunoGen, Inc. Jun 30, 2021 1 $11.4K 4 Jul 2, 2021 SVP & Chief Medical Officer